Trump Mulls Fast-tracking AstraZeneca Covid-19 Vaccine Before Election: Report

U.S. President Donald Trump is considering fast tracking UK-based drug maker AstraZeneca's coronavirus vaccine candidate to make it available in the U.S. ahead of the presidential election in November, the Financial Times reported. The report comes just as the FDA issued an emergency use authorization for investigational convalescent plasma to treat COVID-19 in hospitalized patients.